| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 5.353 | 4.637 | 5.337 | 14.296 | 20.257 | 20.033 |
| Total Income - EUR | - | - | - | - | 5.353 | 4.637 | 5.337 | 14.296 | 20.257 | 20.033 |
| Total Expenses - EUR | - | - | - | - | 6.402 | 7.976 | 9.835 | 11.614 | 15.033 | 18.446 |
| Gross Profit/Loss - EUR | - | - | - | - | -1.049 | -3.339 | -4.498 | 2.682 | 5.223 | 1.587 |
| Net Profit/Loss - EUR | - | - | - | - | -1.103 | -3.384 | -4.551 | 2.539 | 5.021 | 986 |
| Employees | - | - | - | - | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dr. Anatolii Cocoş Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 23 | 18 | 12 | 624 | 243 | 619 |
| Current Assets | - | - | - | - | 490 | 916 | 176 | 1.852 | 2.787 | 1.742 |
| Inventories | - | - | - | - | 90 | 88 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | 0 | 0 | 0 | 93 | 0 | 9 |
| Cash | - | - | - | - | 400 | 828 | 176 | 1.758 | 2.787 | 1.733 |
| Shareholders Funds | - | - | - | - | -1.061 | -4.424 | -8.877 | -6.366 | -1.326 | -333 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 1.595 | 5.358 | 9.066 | 8.842 | 4.356 | 2.694 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Dr. Anatolii Cocoş Med S.r.l.